CClinicalTrials.gg
CompletedNCT04277078Updated Jun 30, 2020

Predicting Intubation of Patients Hospitalised for Acutely Attacked Asthma

An observational study in Intubation Complication and Asthma, sponsored by Hat Yai Medical Education Center. Completed at 1 site in Thailand. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2020-06-30.

Sponsored by Hat Yai Medical Education Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
509
Ages
15 Years and older
Sex
All
01

Study summary

Although the asthmatic treatments currently be effective in term of efficacy of inhaled medications and good clinical outcome including symptom controlled and asthma exacerbation number, the large number of worse event still have been reported. Few cases eventually have been intubated and died even though using optimal medication. In this study, we will search to identify factors that may influence intubation in hospitalised patient with asthmatic attack.

02

Conditions studied

  • Intubation Complication
  • Asthma

Browse trials for

03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's enrollment of 509 is above the median of 150 across 970 observational studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Hat Yai Medical Education Center is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Population in this study is a the patient who had been admitted with moderate to severe asthmatic attack. The study will be retrospective review with data in medical record between year 2016-2018. The baseline characteristic and factors which has a potential to intubation will be recored.

Inclusion criteria

  • Patients who had been admitted and diagnosed as asthmatic attack between year 2016-2018.
  • Patients who have age > 15 year old.

Exclusion criteria

Exclusion Criteria:

  • Non
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
509 participants (actual)
Patient registry
No

Groups and cohorts

  • Intubated asthma attack

    Patients who had been hospitalised with asthma attack, then intubated during hospitalisation.

  • Non-Intubated asthma attack

    Patients who had been hospitalised with asthma attack without intubation during hospitalisation.

06

What researchers measure

Primary outcomes

  1. Number case of intubated patient

    Number case of hospitalized asthmatic attack patients during 2-year review.

    Time frame: Retropectively review 2 years backard between 2017-2018

Secondary outcomes

  1. Number of previous asthma attack before this admission

    Number of previous asthma attack with 12 months before this hospitalization.

    Time frame: 1 year before admission

  2. Blood eosinophil count at admission time

    Blood eosinophil may help predict outcome and risk for intubation.

    Time frame: Retropectively review 2 years backard between 2017-2018

  3. Number patients dead

    Number patient dead during hospitalization

    Time frame: Retropectively review 2 years backard between 2017-2018

07

Study locations

1 site
  • Hatyai Hospital
    Hat Yai, Songkhla 90110, Thailand
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 30, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04277078
Lead sponsor
Hat Yai Medical Education Center
Responsible party
Narongwit Nakwan (Asst.prof, Hat Yai Medical Education Center) — Principal investigator
First posted
Feb 20, 2020
Start date
Feb 1, 2020
Primary completion
May 30, 2020
Completion
May 30, 2020
Last update
Jun 30, 2020

Study contacts

Narongwit Nakwan, M.D.
principal investigator · HatYai Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion